Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer

Clinical trial NCT00372073 · TERMINATED

Trial details

NCT number: NCT00372073
Sponsor: Cyclacel Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2006-08-09
Primary completion: 2009-03-03
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.